Market Overview

Benzinga's Top Pre-Market Gainers

Related RIMM
Blackberry's Investor Strategy
A Peek Into The Market Before The Trading Starts
Related STJ
St. Jude Confirms 5-Year Data from FAME Trial Further Confirms Sustained, Long Term Benefit of FFR-Guided PCI
Benzinga's M&A Chatter for Thursday August 27, 2015
Medtronic Q1 Beats Estimates; Guidance Affirmed (Investor's Business Daily)

Research In Motion Limited (NASDAQ: RIMM) surged 12.18% to $11.51 in the pre-market session. Research In Motion announced its plans to introduce its BB10 phones at the end of January 2013.

St. Jude Medical (NYSE: STJ) moved up 7.65% to $33.77 in the pre-market session. St. Jude's PEG ratio is 0.95.

Star Scientific (NASDAQ: STSI) added 5.11% to $2.47 in the pre-market session. Star Scientific shares have dropped 7.84% over the past 52 weeks, while the S&P 500 index has gained 20.05% in the same period.

Sarepta Therapeutics (NASDAQ: SRPT) soared 3.42% to $29.30 in the pre-market trading. Sarepta Therapeutics' trailing-twelve-month revenue is $43.58 million.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (RIMM + SRPT)

Get Benzinga's Newsletters